HCA Healthcare Inc (NYSE: HCA) is 49.66% higher on its value in year-to-date trading and has touched a low of $215.96 and a high of $409.42 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The HCA stock was last observed hovering at around $401.80 in the last trading session, with the day’s gains setting it 3.31%.
Currently trading at $405.11, the stock is 2.46% and 8.76% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.8 million and changing 0.82% at the moment leaves the stock 24.27% off its SMA200. HCA registered 59.17% gain for a year compared to 6-month gain of 23.62%. The firm has a 50-day simple moving average (SMA 50) of $374.2034 and a 200-day simple moving average (SMA200) of $326.74115.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 4.28% loss in the last 1 month and extending the period to 3 months gives it a 18.98%, and is 1.31% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.47% over the week and 1.81% over the month.
HCA Healthcare Inc (HCA) has around 310000 employees, a market worth around $104.55B and $68.35B in sales. Current P/E ratio is 19.01 and Fwd P/E is 16.31. Profit margin for the company is 8.40%. Distance from 52-week low is 87.59% and -1.05% from its 52-week high. The company has generated returns on investments over the last 12 months (15.68%).
The EPS is expected to grow by 18.15% this year
1608.0 institutions hold shares in HCA Healthcare Inc (HCA), with institutional investors hold 89.57% of the company’s shares. The shares outstanding are 265.54M, and float is at 185.65M with Short Float at 2.05%. Institutions hold 64.60% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 16.84 million shares valued at $5.41 billion. The investor’s holdings represent 6.3976 of the HCA Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 14.85 million shares valued at $4.77 billion to account for 5.6425 of the shares outstanding. The other top investors are SANDERS CAPITAL, LLC which holds 11.52 million shares representing 4.3769 and valued at over $3.7 billion, while WELLINGTON MANAGEMENT GROUP LLP holds 4.0955 of the shares totaling 10.78 million with a market value of $3.46 billion.
HCA Healthcare Inc (HCA) Insider Activity
The most recent transaction is an insider sale by Cuffe Michael S., the company’s EVP and Chief Clinical Officer. SEC filings show that Cuffe Michael S. sold 8,358 shares of the company’s common stock on Sep 12 ’24 at a price of $385.42 per share for a total of $3.22 million. Following the sale, the insider now owns 29678.0 shares.
Still, SEC filings show that on Jul 31 ’24, Whalen Kathleen M (SVP & Chief Ethics Officer) disposed off 2,987 shares at an average price of $363.51 for $1.09 million. The insider now directly holds 9,454 shares of HCA Healthcare Inc (HCA).
